1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Precision Cancer Diagnostic Tests Revenue
1.4 Market Analysis by Type
1.4.1 Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Imaging
1.4.3 Molecular
1.4.4 Histology/Cytology
1.4.5 Tumor Marker Immunoassays
1.4.6 POC Colon Cancer Tests
1.5 Market by Application
1.5.1 Global Precision Cancer Diagnostic Tests Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Precision Cancer Diagnostic Tests Market Perspective (2015-2026)
2.2 Precision Cancer Diagnostic Tests Growth Trends by Regions
2.2.1 Precision Cancer Diagnostic Tests Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Precision Cancer Diagnostic Tests Historic Market Share by Regions (2015-2020)
2.2.3 Precision Cancer Diagnostic Tests Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Precision Cancer Diagnostic Tests Market Growth Strategy
2.3.6 Primary Interviews with Key Precision Cancer Diagnostic Tests Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Precision Cancer Diagnostic Tests Players by Market Size
3.1.1 Global Top Precision Cancer Diagnostic Tests Players by Revenue (2015-2020)
3.1.2 Global Precision Cancer Diagnostic Tests Revenue Market Share by Players (2015-2020)
3.1.3 Global Precision Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Precision Cancer Diagnostic Tests Market Concentration Ratio
3.2.1 Global Precision Cancer Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Precision Cancer Diagnostic Tests Revenue in 2019
3.3 Precision Cancer Diagnostic Tests Key Players Head office and Area Served
3.4 Key Players Precision Cancer Diagnostic Tests Product Solution and Service
3.5 Date of Enter into Precision Cancer Diagnostic Tests Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Precision Cancer Diagnostic Tests Historic Market Size by Type (2015-2020)
4.2 Global Precision Cancer Diagnostic Tests Forecasted Market Size by Type (2021-2026)
5 Precision Cancer Diagnostic Tests Breakdown Data by Application (2015-2026)
5.1 Global Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)
5.2 Global Precision Cancer Diagnostic Tests Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Precision Cancer Diagnostic Tests Market Size (2015-2020)
6.2 Precision Cancer Diagnostic Tests Key Players in North America (2019-2020)
6.3 North America Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)
6.4 North America Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)
7 Europe
7.1 Europe Precision Cancer Diagnostic Tests Market Size (2015-2020)
7.2 Precision Cancer Diagnostic Tests Key Players in Europe (2019-2020)
7.3 Europe Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)
7.4 Europe Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)
8 China
8.1 China Precision Cancer Diagnostic Tests Market Size (2015-2020)
8.2 Precision Cancer Diagnostic Tests Key Players in China (2019-2020)
8.3 China Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)
8.4 China Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)
9 Japan
9.1 Japan Precision Cancer Diagnostic Tests Market Size (2015-2020)
9.2 Precision Cancer Diagnostic Tests Key Players in Japan (2019-2020)
9.3 Japan Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)
9.4 Japan Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Precision Cancer Diagnostic Tests Market Size (2015-2020)
10.2 Precision Cancer Diagnostic Tests Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)
10.4 Southeast Asia Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)
11 India
11.1 India Precision Cancer Diagnostic Tests Market Size (2015-2020)
11.2 Precision Cancer Diagnostic Tests Key Players in India (2019-2020)
11.3 India Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)
11.4 India Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Precision Cancer Diagnostic Tests Market Size (2015-2020)
12.2 Precision Cancer Diagnostic Tests Key Players in Central & South America (2019-2020)
12.3 Central & South America Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)
12.4 Central & South America Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Company 1
13.1.1 Company 1 Company Details
13.1.2 Company 1 Business Overview and Its Total Revenue
13.1.3 Company 1 Precision Cancer Diagnostic Tests Introduction
13.1.4 Company 1 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020))
13.1.5 Company 1 Recent Development
13.2 Company 2
13.2.1 Company 2 Company Details
13.2.2 Company 2 Business Overview and Its Total Revenue
13.2.3 Company 2 Precision Cancer Diagnostic Tests Introduction
13.2.4 Company 2 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
13.2.5 Company 2 Recent Development
13.3 Company 3
13.3.1 Company 3 Company Details
13.3.2 Company 3 Business Overview and Its Total Revenue
13.3.3 Company 3 Precision Cancer Diagnostic Tests Introduction
13.3.4 Company 3 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
13.3.5 Company 3 Recent Development
13.4 Company 4
13.4.1 Company 4 Company Details
13.4.2 Company 4 Business Overview and Its Total Revenue
13.4.3 Company 4 Precision Cancer Diagnostic Tests Introduction
13.4.4 Company 4 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
13.4.5 Company 4 Recent Development
13.5 Company 5
13.5.1 Company 5 Company Details
13.5.2 Company 5 Business Overview and Its Total Revenue
13.5.3 Company 5 Precision Cancer Diagnostic Tests Introduction
13.5.4 Company 5 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
13.5.5 Company 5 Recent Development
13.6 Company 6
13.6.1 Company 6 Company Details
13.6.2 Company 6 Business Overview and Its Total Revenue
13.6.3 Company 6 Precision Cancer Diagnostic Tests Introduction
13.6.4 Company 6 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
13.6.5 Company 6 Recent Development
13.7 Company 7
13.7.1 Company 7 Company Details
13.7.2 Company 7 Business Overview and Its Total Revenue
13.7.3 Company 7 Precision Cancer Diagnostic Tests Introduction
13.7.4 Company 7 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
13.7.5 Company 7 Recent Development
13.8 Company 8
13.8.1 Company 8 Company Details
13.8.2 Company 8 Business Overview and Its Total Revenue
13.8.3 Company 8 Precision Cancer Diagnostic Tests Introduction
13.8.4 Company 8 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
13.8.5 Company 8 Recent Development
13.9 Company 9
13.9.1 Company 9 Company Details
13.9.2 Company 9 Business Overview and Its Total Revenue
13.9.3 Company 9 Precision Cancer Diagnostic Tests Introduction
13.9.4 Company 9 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
13.9.5 Company 9 Recent Development
13.10 Company 10
13.10.1 Company 10 Company Details
13.10.2 Company 10 Business Overview and Its Total Revenue
13.10.3 Company 10 Precision Cancer Diagnostic Tests Introduction
13.10.4 Company 10 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
13.10.5 Company 10 Recent Development
13.11 Company 11
10.11.1 Company 11 Company Details
10.11.2 Company 11 Business Overview and Its Total Revenue
10.11.3 Company 11 Precision Cancer Diagnostic Tests Introduction
10.11.4 Company 11 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
10.11.5 Company 11 Recent Development
13.12 Company 12
10.12.1 Company 12 Company Details
10.12.2 Company 12 Business Overview and Its Total Revenue
10.12.3 Company 12 Precision Cancer Diagnostic Tests Introduction
10.12.4 Company 12 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
10.12.5 Company 12 Recent Development
13.13 Company 13
10.13.1 Company 13 Company Details
10.13.2 Company 13 Business Overview and Its Total Revenue
10.13.3 Company 13 Precision Cancer Diagnostic Tests Introduction
10.13.4 Company 13 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
10.13.5 Company 13 Recent Development
13.14 Company 14
10.14.1 Company 14 Company Details
全球精密癌癥診斷測試市場規模，現狀和展望二零二零年至2026年
10.14.2 Company 14 Business Overview and Its Total Revenue
10.14.3 Company 14 Precision Cancer Diagnostic Tests Introduction
10.14.4 Company 14 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
10.14.5 Company 14 Recent Development
13.15 Company 15
10.15.1 Company 15 Company Details
10.15.2 Company 15 Business Overview and Its Total Revenue
10.15.3 Company 15 Precision Cancer Diagnostic Tests Introduction
10.15.4 Company 15 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
10.15.5 Company 15 Recent Development
13.16 Company 16
10.16.1 Company 16 Company Details
10.16.2 Company 16 Business Overview and Its Total Revenue
10.16.3 Company 16 Precision Cancer Diagnostic Tests Introduction
10.16.4 Company 16 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
10.16.5 Company 16 Recent Development
13.17 Company 17
10.17.1 Company 17 Company Details
10.17.2 Company 17 Business Overview and Its Total Revenue
10.17.3 Company 17 Precision Cancer Diagnostic Tests Introduction
10.17.4 Company 17 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
10.17.5 Company 17 Recent Development
13.18 Company 18
10.18.1 Company 18 Company Details
10.18.2 Company 18 Business Overview and Its Total Revenue
10.18.3 Company 18 Precision Cancer Diagnostic Tests Introduction
10.18.4 Company 18 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
10.18.5 Company 18 Recent Development
13.19 Company 19
10.19.1 Company 19 Company Details
10.19.2 Company 19 Business Overview and Its Total Revenue
10.19.3 Company 19 Precision Cancer Diagnostic Tests Introduction
10.19.4 Company 19 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
10.19.5 Company 19 Recent Development
13.20 Company 20
10.20.1 Company 20 Company Details
10.20.2 Company 20 Business Overview and Its Total Revenue
10.20.3 Company 20 Precision Cancer Diagnostic Tests Introduction
10.20.4 Company 20 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
10.20.5 Company 20 Recent Development
13.21 Company 21
10.21.1 Company 21 Company Details
10.21.2 Company 21 Business Overview and Its Total Revenue
10.21.3 Company 21 Precision Cancer Diagnostic Tests Introduction
10.21.4 Company 21 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
10.21.5 Company 21 Recent Development
13.22 Company 22
10.22.1 Company 22 Company Details
10.22.2 Company 22 Business Overview and Its Total Revenue
10.22.3 Company 22 Precision Cancer Diagnostic Tests Introduction
10.22.4 Company 22 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
10.22.5 Company 22 Recent Development
13.23 Company 23
10.23.1 Company 23 Company Details
10.23.2 Company 23 Business Overview and Its Total Revenue
10.23.3 Company 23 Precision Cancer Diagnostic Tests Introduction
10.23.4 Company 23 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
10.23.5 Company 23 Recent Development
13.24 Company 24
10.24.1 Company 24 Company Details
10.24.2 Company 24 Business Overview and Its Total Revenue
10.24.3 Company 24 Precision Cancer Diagnostic Tests Introduction
10.24.4 Company 24 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
10.24.5 Company 24 Recent Development
13.25 Company 25
10.25.1 Company 25 Company Details
10.25.2 Company 25 Business Overview and Its Total Revenue
10.25.3 Company 25 Precision Cancer Diagnostic Tests Introduction
10.25.4 Company 25 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
10.25.5 Company 25 Recent Development
13.26 Company 26
10.26.1 Company 26 Company Details
10.26.2 Company 26 Business Overview and Its Total Revenue
10.26.3 Company 26 Precision Cancer Diagnostic Tests Introduction
10.26.4 Company 26 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
10.26.5 Company 26 Recent Development
13.27 Company 27
10.27.1 Company 27 Company Details
10.27.2 Company 27 Business Overview and Its Total Revenue
10.27.3 Company 27 Precision Cancer Diagnostic Tests Introduction
10.27.4 Company 27 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
10.27.5 Company 27 Recent Development
13.28 Company 28
10.28.1 Company 28 Company Details
10.28.2 Company 28 Business Overview and Its Total Revenue
10.28.3 Company 28 Precision Cancer Diagnostic Tests Introduction
10.28.4 Company 28 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
10.28.5 Company 28 Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Precision Cancer Diagnostic Tests Key Market Segments
Table 2. Key Players Covered: Ranking by Precision Cancer Diagnostic Tests Revenue
Table 3. Ranking of Global Top Precision Cancer Diagnostic Tests Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Imaging
Table 6. Key Players of Molecular
Table 7. Key Players of Histology/Cytology
Table 8. Key Players of Tumor Marker Immunoassays
Table 9. Key Players of POC Colon Cancer Tests
Table 10. Global Precision Cancer Diagnostic Tests Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Precision Cancer Diagnostic Tests Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Precision Cancer Diagnostic Tests Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Precision Cancer Diagnostic Tests Market Share by Regions (2015-2020)
Table 14. Global Precision Cancer Diagnostic Tests Forecasted Market Size by Regions (2021-2026) (US$ Million)
全球精密癌癥診斷測試市場規模，現狀和展望二零二零年至2026年
Table 15. Global Precision Cancer Diagnostic Tests Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Precision Cancer Diagnostic Tests Market Growth Strategy
Table 20. Main Points Interviewed from Key Precision Cancer Diagnostic Tests Players
Table 21. Global Precision Cancer Diagnostic Tests Revenue by Players (2015-2020) (Million US$)
Table 22. Global Precision Cancer Diagnostic Tests Market Share by Players (2015-2020)
Table 23. Global Top Precision Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precision Cancer Diagnostic Tests as of 2019)
Table 24. Global Precision Cancer Diagnostic Tests by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Precision Cancer Diagnostic Tests Product Solution and Service
Table 27. Date of Enter into Precision Cancer Diagnostic Tests Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Precision Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 30. Global Precision Cancer Diagnostic Tests Market Size Share by Type (2015-2020)
Table 31. Global Precision Cancer Diagnostic Tests Revenue Market Share by Type (2021-2026)
Table 32. Global Precision Cancer Diagnostic Tests Market Size Share by Application (2015-2020)
Table 33. Global Precision Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 34. Global Precision Cancer Diagnostic Tests Market Size Share by Application (2021-2026)
Table 35. North America Key Players Precision Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Precision Cancer Diagnostic Tests Market Share (2019-2020)
Table 37. North America Precision Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 38. North America Precision Cancer Diagnostic Tests Market Share by Type (2015-2020)
Table 39. North America Precision Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 40. North America Precision Cancer Diagnostic Tests Market Share by Application (2015-2020)
Table 41. Europe Key Players Precision Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Precision Cancer Diagnostic Tests Market Share (2019-2020)
Table 43. Europe Precision Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Precision Cancer Diagnostic Tests Market Share by Type (2015-2020)
Table 45. Europe Precision Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Precision Cancer Diagnostic Tests Market Share by Application (2015-2020)
Table 47. China Key Players Precision Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 48. China Key Players Precision Cancer Diagnostic Tests Market Share (2019-2020)
Table 49. China Precision Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 50. China Precision Cancer Diagnostic Tests Market Share by Type (2015-2020)
Table 51. China Precision Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 52. China Precision Cancer Diagnostic Tests Market Share by Application (2015-2020)
Table 53. Japan Key Players Precision Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Precision Cancer Diagnostic Tests Market Share (2019-2020)
Table 55. Japan Precision Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Precision Cancer Diagnostic Tests Market Share by Type (2015-2020)
Table 57. Japan Precision Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Precision Cancer Diagnostic Tests Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Precision Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Precision Cancer Diagnostic Tests Market Share (2019-2020)
Table 61. Southeast Asia Precision Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Precision Cancer Diagnostic Tests Market Share by Type (2015-2020)
Table 63. Southeast Asia Precision Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Precision Cancer Diagnostic Tests Market Share by Application (2015-2020)
Table 65. India Key Players Precision Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 66. India Key Players Precision Cancer Diagnostic Tests Market Share (2019-2020)
Table 67. India Precision Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 68. India Precision Cancer Diagnostic Tests Market Share by Type (2015-2020)
Table 69. India Precision Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 70. India Precision Cancer Diagnostic Tests Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Precision Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Precision Cancer Diagnostic Tests Market Share (2019-2020)
Table 73. Central & South America Precision Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Precision Cancer Diagnostic Tests Market Share by Type (2015-2020)
Table 75. Central & South America Precision Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Precision Cancer Diagnostic Tests Market Share by Application (2015-2020)
Table 77. Company 1 Company Details
Table 78. Company 1 Business Overview
Table 79. Company 1 Product
Table 80. Company 1 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 81. Company 1 Recent Development
Table 82. Company 2 Company Details
Table 83. Company 2 Business Overview
Table 84. Company 2 Product
Table 85. Company 2 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 86. Company 2 Recent Development
Table 87. Company 3 Company Details
Table 88. Company 3 Business Overview
Table 89. Company 3 Product
Table 90. Company 3 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 91. Company 3 Recent Development
Table 92. Company 4 Company Details
Table 93. Company 4 Business Overview
Table 94. Company 4 Product
Table 95. Company 4 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 96. Company 4 Recent Development
Table 97. Company 5 Company Details
Table 98. Company 5 Business Overview
Table 99. Company 5 Product
Table 100. Company 5 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 101. Company 5 Recent Development
Table 102. Company 6 Company Details
Table 103. Company 6 Business Overview
Table 104. Company 6 Product
Table 105. Company 6 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 106. Company 6 Recent Development
Table 107. Company 7 Company Details
Table 108. Company 7 Business Overview
Table 109. Company 7 Product
Table 110. Company 7 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 111. Company 7 Recent Development
Table 112. Company 8 Business Overview
Table 113. Company 8 Product
Table 114. Company 8 Company Details
Table 115. Company 8 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 116. Company 8 Recent Development
Table 117. Company 9 Company Details
Table 118. Company 9 Business Overview
Table 119. Company 9 Product
Table 120. Company 9 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 121. Company 9 Recent Development
Table 122. Company 10 Company Details
Table 123. Company 10 Business Overview
Table 124. Company 10 Product
quánqiú jīngmì áizhèng zhěnduàn cèshìshìchǎng guīmó, xiànzhuàng hé zhǎnwàng èr líng èr líng nián zhì 2026 nián
Table 125. Company 10 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 126. Company 10 Recent Development
Table 127. Company 11 Company Details
Table 128. Company 11 Business Overview
Table 129. Company 11 Product
Table 130. Company 11 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 131. Company 11 Recent Development
Table 132. Company 12 Company Details
Table 133. Company 12 Business Overview
Table 134. Company 12 Product
Table 135. Company 12 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 136. Company 12 Recent Development
Table 137. Company 13 Company Details
Table 138. Company 13 Business Overview
Table 139. Company 13 Product
Table 140. Company 13 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 141. Company 13 Recent Development
Table 142. Company 14 Company Details
Table 143. Company 14 Business Overview
Table 144. Company 14 Product
Table 145. Company 14 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 146. Company 14 Recent Development
Table 147. Company 15 Company Details
Table 148. Company 15 Business Overview
Table 149. Company 15 Product
Table 150. Company 15 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 151. Company 15 Recent Development
Table 152. Company 16 Company Details
Table 153. Company 16 Business Overview
Table 154. Company 16 Product
Table 155. Company 16 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 156. Company 16 Recent Development
Table 157. Company 17 Company Details
Table 158. Company 17 Business Overview
Table 159. Company 17 Product
Table 160. Company 17 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 161. Company 17 Recent Development
Table 162. Company 18 Company Details
Table 163. Company 18 Business Overview
Table 164. Company 18 Product
Table 165. Company 18 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 166. Company 18 Recent Development
Table 167. Company 19 Company Details
Table 168. Company 19 Business Overview
Table 169. Company 19 Product
Table 170. Company 19 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 171. Company 19 Recent Development
Table 172. Company 20 Company Details
Table 173. Company 20 Business Overview
Table 174. Company 20 Product
Table 175. Company 20 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 176. Company 20 Recent Development
Table 177. Company 21 Company Details
Table 178. Company 21 Business Overview
Table 179. Company 21 Product
Table 180. Company 21 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 181. Company 21 Recent Development
Table 182. Company 22 Company Details
Table 183. Company 22 Business Overview
Table 184. Company 22 Product
Table 185. Company 22 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 186. Company 22 Recent Development
Table 187. Company 23 Company Details
Table 188. Company 23 Business Overview
Table 189. Company 23 Product
Table 190. Company 23 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 191. Company 23 Recent Development
Table 192. Company 24 Company Details
Table 193. Company 24 Business Overview
Table 194. Company 24 Product
Table 195. Company 24 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 196. Company 24 Recent Development
Table 197. Company 25 Company Details
Table 198. Company 25 Business Overview
Table 199. Company 25 Product
Table 200. Company 25 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 201. Company 25 Recent Development
Table 202. Company 26 Company Details
Table 203. Company 26 Business Overview
Table 204. Company 26 Product
Table 205. Company 26 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 206. Company 26 Recent Development
Table 207. Company 27 Company Details
Table 208. Company 27 Business Overview
Table 209. Company 27 Product
Table 210. Company 27 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 211. Company 27 Recent Development
Table 212. Company 28 Company Details
Table 213. Company 28 Business Overview
Table 214. Company 28 Product
Table 215. Company 28 Revenue in Precision Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 216. Company 28 Recent Development
Table 217. Research Programs/Design for This Report
Table 218. Key Data Information from Secondary Sources
Table 219. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Precision Cancer Diagnostic Tests Market Share by Type: 2020 VS 2026
Figure 2. Imaging Features
Figure 3. Molecular Features
Figure 4. Histology/Cytology Features
Figure 5. Tumor Marker Immunoassays Features
Figure 6. POC Colon Cancer Tests Features
Figure 7. Global Precision Cancer Diagnostic Tests Market Share by Application: 2020 VS 2026
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
グローバル?精密がんの診斷には、市場規模、ステータスおよび予測2020年から2026年をテスト
Figure 10. Other Case Studies
Figure 11. Precision Cancer Diagnostic Tests Report Years Considered
Figure 12. Global Precision Cancer Diagnostic Tests Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Precision Cancer Diagnostic Tests Market Share by Regions: 2020 VS 2026
Figure 14. Global Precision Cancer Diagnostic Tests Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Precision Cancer Diagnostic Tests Market Share by Players in 2019
Figure 17. Global Top Precision Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precision Cancer Diagnostic Tests as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Precision Cancer Diagnostic Tests Revenue in 2019
Figure 19. North America Precision Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Precision Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Precision Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Precision Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Precision Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Precision Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Precision Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Company 1 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Company 1 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)
Figure 28. Company 2 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Company 2 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)
Figure 30. Company 3 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Company 3 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)
Figure 32. Company 4 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Company 4 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)
Figure 34. Company 5 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Company 5 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)
Figure 36. Company 6 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Company 6 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)
Figure 38. Company 7 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Company 7 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)
Figure 40. Company 8 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Company 8 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)
Figure 42. Company 9 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Company 9 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)
Figure 44. Company 10 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Company 10 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)
Figure 46. Company 11 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Company 11 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)
Figure 48. Company 12 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Company 12 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)
Figure 50. Company 13 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Company 13 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)
Figure 52. Company 14 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Company 14 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)
Figure 54. Company 15 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Company 15 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)
Figure 56. Company 16 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Company 16 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)
Figure 58. Company 17 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Company 17 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)
Figure 60. Company 18 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Company 18 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)
Figure 62. Company 19 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Company 19 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)
Figure 64. Company 20 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Company 20 Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2015-2020)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
省略………
請撥打：400 612 8668、010-6618 1099、66182099、66183099
Email：KF@Cir.cn 下載《訂購協議》 ┊ 【網上訂購】 ┊ 了解“訂購流程”
京公網安備 11010802027365號